| Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients M Pirmohamed, S James, S Meakin, C Green, AK Scott, TJ Walley, ... Bmj 329 (7456), 15-19, 2004 | 4579 | 2004 |
| The UK general practice research database T Walley, A Mantgani The Lancet 350 (9084), 1097-1099, 1997 | 736 | 1997 |
| Influences on GPs’ decision to prescribe new drugs—the importance of who says what H Prosser, S Almond, T Walley Family practice 20 (1), 61-68, 2003 | 501 | 2003 |
| Why do GPs not implement evidence-based guidelines? A descriptive study M Cranney, E Warren, S Barton, K Gardner, T Walley Family practice 18 (4), 359-363, 2001 | 307 | 2001 |
| Regulating pharmaceuticals in Europe: striving for efficiency, equity and quality: striving for efficiency, equity and quality E Mossialos, M Mrazek, T Walley McGraw-hill education (UK), 2004 | 292 | 2004 |
| Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation. C McLeod, A Bagust, A Boland, P Dagenais, R Dickson, Y Dundar, ... Health technology assessment (Winchester, England) 11 (28), 1-158, iii, 2007 | 275 | 2007 |
| Teaching safe and effective prescribing in UK medical schools: a core curriculum for tomorrow's doctors S Maxwell, T Walley British journal of clinical pharmacology 55 (6), 496-503, 2003 | 274 | 2003 |
| The impact of non‐compliance on the cost‐effectiveness of pharmaceuticals: a review of the literature DA Hughes, A Bagust, A Haycox, T Walley Health economics 10 (7), 601-615, 2001 | 251 | 2001 |
| Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997–2003 T Walley, P Folino‐Gallo, P Stephens, E Van Ganse, EuroMedStat Group British journal of clinical pharmacology 60 (5), 543-551, 2005 | 247 | 2005 |
| Comparative efficacy of newer hypnotic drugs for the short‐term management of insomnia: a systematic review and meta‐analysis Y Dündar, S Dodd, J Strobl, A Boland, R Dickson, T Walley Human Psychopharmacology: Clinical and Experimental 19 (5), 305-322, 2004 | 197 | 2004 |
| Pharmacoeconomics T Walley Getting Health Economics into Practice, 137-146, 2018 | 184 | 2018 |
| Drug-eluting stents: an early systematic review to inform policy RA Hill, Y Dündar, A Bakhai, R Dickson, T Walley European heart journal 25 (11), 902-919, 2004 | 184 | 2004 |
| Variations and increase in use of statins across Europe: data from administrative databases T Walley, P Folino-Gallo, U Schwabe, E van Ganse Bmj 328 (7436), 385-386, 2004 | 168 | 2004 |
| Economic evaluation under managed competition: evidence from the UK M Drummond, J Cooke, T Walley Social science & medicine 45 (4), 583-595, 1997 | 168 | 1997 |
| Coronary artery stents: a rapid systematic review and economic evaluation R Hill, A Bagust, A Bakhai, R Dickson, Y Dündar, A Haycox, RM Mota, ... NIHR Health Technology Assessment programme: Executive Summaries, 2004 | 158 | 2004 |
| Cytochrome P450 testing for prescribing antipsychotics in adults with schizophrenia: systematic review and meta-analyses N Fleeman, Y Dundar, R Dickson, A Jorgensen, S Pushpakom, C McLeod, ... The pharmacogenomics journal 11 (1), 1-14, 2011 | 155 | 2011 |
| Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation. Y Dündar, A Boland, J Strobl, S Dodd, A Haycox, A Bagust, J Bogg, ... Health technology assessment (Winchester, England) 8 (24), iii-x, 1, 2004 | 154 | 2004 |
| Evaluating Progestogens for Preventing Preterm birth International Collaborative (EPPPIC): meta-analysis of individual participant data from randomised controlled trials LA Stewart, M Simmonds, L Duley, A Llewellyn, S Sharif, RAE Walker, ... The Lancet 397 (10280), 1183-1194, 2021 | 145 | 2021 |
| The Iranian health insurance system; past experiences, present challenges and future strategies M Davari, A Haycox, T Walley Iranian journal of public health 41 (9), 1, 2012 | 143 | 2012 |
| Clinical guidelines—the hidden costs A Haycox, A Bagust, T Walley BMJ 318 (7180), 391-393, 1999 | 142 | 1999 |
